Written by Daniel McCartney PhD, Principal Data Scientist – Translational Genomics This year’s AD/PD brought together more than 5,500 delegates from over 70 countries, reinforcing its status as one of the world’s leading meetings in neurodegenerative disease research. A clear message across the conference was that the field is moving toward greater biological precision, with… Continue reading Key Reflections from AD/PD 2026
Tag: Agility in Pharma
Accelerating R&D Delivery through Agility and Intelligent Prioritisation
Written by Daniel McCartney, PhD, Lead Bioinformatician Pharmaceutical research and development operates within one of the most complex and tightly regulated environments in the world. The work is intellectually demanding, resource intensive, and subject to pressures that range from rapidly evolving science to changing patient needs and global health priorities. Despite this, many R&D organisations… Continue reading Accelerating R&D Delivery through Agility and Intelligent Prioritisation